2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999

• December 6, 2001
  Cypress Files IND to Begin Clinical Testing of Drug Candidate For Treatment of Fibromyalgia Syndrome
• October 16, 2001
  Cypress Bioscience Names Lisa Walters-Hoffert Executive Vice President and CFO
• August 13, 2001
  Cypress Bioscience Announces Second Quarter 2001 Results
• August 1, 2001
  Cypress Bioscience In-Licenses bioMérieux Pierre Fabre Drug For Development in Fibromyalgia Treatment
• July 27, 2001
  Cypress Bioscience Discussing Progress with Fibromyalgia Initiative at Annual Meeting
• July 19, 2001
  Cypress Bioscience Announces Formation of Psychopharmacology Advisory Board for Fibromyalgia
• July 11, 2001
  Cypress Bioscience Launches Genomic Research Program for Fibromyalgia
• July 5, 2001
  Cypress Bioscience Names John N. Bonfiglio, Ph.D. as Executive Vice President and Chief Operating Officer
• June 28, 2001
  Cypress Bioscience Appoints Sheldon Drobny to Board of Directors
• June 25, 2001
  Cypress Bioscience Appoints Martin B. Keller, M.D., to Board of Directors
• May 22, 2001
  Cypress Bioscience Announces Formation of New Scientific Advisory Board for Fibromyalgia Initiative
• May 14, 2001
  Cypress Bioscience Announces First Quarter 2001 Results
• April 4, 2001
  Cypress Bioscience, Inc. Appoints Charles B. Nemeroff, M.D. Ph.D. to Board of Directors. Building Team to Support New Fibromyalgia Program
• April 2, 2001
  Cypress Bioscience and Georgetown University Form Alliance on Discovery and Development of Novel Treatments for Fibromyalgia Syndrome
• March 9, 2001
  Cypress Bioscience Announces Fourth Quarter and Fiscal Year End 2000 Results
• February 14, 2001
  Cypress Bioscience Announces Expansion of Agreement with Sanquin Blood Supply Foundation
• January 22, 2001
  Cypress Bioscience Announces Restructuring of Prosorba Column Agreement with Fresenius